Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

The rise of ADP-ribose–ubiquitin

Post-translational modifications show mechanistic crosstalk, exemplified by the ADP-ribose–ubiquitin hybrid signal, in which one post-translational modification modifies another. This Comment highlights its discovery, mechanistic basis and functional consequences, and outlines critical questions for understanding this emerging signaling paradigm.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Ub and ADPr modify each other.

References

  1. Suskiewicz, M. J., Prokhorova, E., Rack, J. G. M. & Ahel, I. Cell 186, 4475–4495 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Dikic, I. & Schulman, B. A. Nat. Rev. Mol. Cell Biol. 24, 273–287 (2023).

    Article  CAS  PubMed  Google Scholar 

  3. DaRosa, P. A. et al. Nature 517, 223–226 (2015).

    Article  CAS  PubMed  Google Scholar 

  4. Zhu, K. et al. Sci. Adv. 8, eadd4253 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Zhu, K. et al. Nucleic Acids Res. 52, 801–815 (2024).

    Article  CAS  PubMed  Google Scholar 

  6. Yang, C.-S. et al. Mol. Cell 66, 503–516.e5 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Chatrin, C. et al. Sci. Adv. 6, eabc0418 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Kolvenbach, A. et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-025-01974-5 (2025).

    Article  PubMed  Google Scholar 

  9. Bejan, D. S., Lacoursiere, R. E., Pruneda, J. N. & Cohen, M. S. EMBO J. 44, 2211–2231 (2025).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wierbiłowicz, K. et al. EMBO J. https://doi.org/10.1038/s44318-025-00510-4 (2025).

  11. Stokes, M.S. et al. Preprint at bioRxiv https://doi.org/10.1101/2025.04.07.647692 (2025).

  12. Perrard, J., Gao, K., Ring, K. & Smith, S. Preprint at bioRxiv https://doi.org/10.1101/2025.04.09.648013 (2025).

  13. Kar, P. et al. EMBO J. 43, 2929–2953 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Dukic, N. et al. Sci. Adv. 9, eadi2687 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kloet, M. S. et al. Nat. Commun. 16, 6319 (2025).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank M. Suskiewicz, J. Ahel and R. Smith for comments. Work in K.Z.’s laboratory is supported by the Shanghai Pujiang Program (24PJD028). Work in I.A.’s laboratory is supported by the Wellcome Trust (223107 and 302632), the Biotechnology and Biological Sciences Research Council (BB/R007195/1 and BB/W016613/1), the Ovarian Cancer Research Alliance (813369), the Oxford University Challenge Seed Fund (USCF 456) and Cancer Research UK (C35050/A22284).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ivan Ahel.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chatrin, C., Zhu, K. & Ahel, I. The rise of ADP-ribose–ubiquitin. Nat Struct Mol Biol 32, 1582–1585 (2025). https://doi.org/10.1038/s41594-025-01651-0

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41594-025-01651-0

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing